BioMap

About:

BioMap is a pioneer in life science AI Foundation Models

Website: http://www.biomap.com/

Twitter/X: BiomapI

Top Investors: Hong Kong Investment Corporation Limited, Baidu, BlueRun Ventures, Legend Capital, Xianghe Capital

Description:

Founded in 2020 by Robin Li and Wei Liu, BioMap is a disruptive life science AI company responsible for building xTrimo, the first and largest protein-centric large language model platform. Their technology allows scientists to model life more accurately, from proteins to a system level, and extract novel insights and predictions from limited data. Supported by an international, cross-functional team of over 300 experts, BioMap is solving critical, protein-related drug development problems and charting a course to radically improve patients’ lives.

Total Funding Amount:

$100M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2020-11-16

Contact Email:

info(AT)biomap.com

Founders:

Robin Li, Wei Liu

Number of Employees:

251-500

Last Funding Date:

2024-06-19

IPO Status:

Private

© 2024 MyAiNote.com